Drug recall
Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159
FDA recall event 74126 · Class II · Allergan Sales, LLC
Key facts
| Event ID | 74126 |
|---|---|
| Recall numbers | D-1064-2016, D-1065-2016 |
| Recalling firm | Allergan Sales, LLC |
| Product type | Drugs |
| Products | Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159, Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed Content Uniformity Specifications. |
| Initiation date | May 10, 2016 |
| Report date | Jul 13, 2016 |
| Termination date | Dec 6, 2017 |
| City | Waco |
| State | TX |
| Country | United States |
| FEI number | 1643525 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: